Iressa and Benadryl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Iressa (gefitinib) and Benadryl (diphenhydramine hydrochloride). Common drug interactions include fatigue among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Iressa and Benadryl. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Iressa?

Iressa has active ingredients of gefitinib. eHealthMe is studying from 10,102 Iressa users. Check the latest studies of Iressa.

What is Benadryl?

Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in allergies. eHealthMe is studying from 104,955 Benadryl users. Check the latest studies of Benadryl.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

16 people who take Iressa and Benadryl together, and have interactions are studied.

Iressa and Benadryl drug interactions.

What are the common drug interactions of Iressa and Benadryl, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Interstitial lung disease
  3. Hypoxia (low oxygen in tissues)
  4. International normalised ratio increased
  5. Performance status decreased
  6. Pulmonary embolism (blockage of the main artery of the lung)
  7. Atelectasis (partial or complete collapse of the lung)
  8. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Cystitis haemorrhagic (blood in the urine and painful voiding)

male:

  1. Death
  2. Rash
  3. Nodule (a growth of abnormal tissue)
  4. Constipation
  5. Disease progression
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea (difficult or laboured respiration)
  8. Febrile neutropenia (fever with reduced white blood cells)
  9. Hallucination (an experience involving the perception of something not present)
  10. Increased upper airway secretion

What are the common drug interactions of Iressa and Benadryl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Dysphagia (a condition in which swallowing is difficult or painful)
  2. Hallucination (an experience involving the perception of something not present)
  3. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

20-29:

n/a

30-39:

n/a

40-49:

  1. Death
  2. Malignant pleural effusion (a condition in which cancer causes an abnormal amount of fluid to collect between the thin layers of tissue lining of lung)

50-59:

  1. Constipation
  2. Splenic infarction (tissue damage of spleen)

60+:

  1. Interstitial lung disease
  2. Pleural effusion (water on the lungs)
  3. Diarrhoea
  4. Gilbert's syndrome (liver condition in which the liver doesn't properly process a substance called bilirubin)
  5. Hepatic enzyme increased
  6. Malignant neoplasm progression (cancer tumour came back)
  7. Nodule (a growth of abnormal tissue)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  10. Cystitis haemorrhagic (blood in the urine and painful voiding)

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 31.25%
  2. Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 12.50%
  3. Breast Cancer Metastatic: 2 people, 12.50%
  4. Breast Cancer Male: 2 people, 12.50%
  5. Tracheal Cancer (cancer of trachea): 1 person, 6.25%
  6. Renal Cell Carcinoma (a kidney cancer): 1 person, 6.25%
  7. Papilloma (small, noncancerous (benign) tumour): 1 person, 6.25%
  8. Malignant Respiratory Tract Neoplasm (cancer tumour of respiratory tract): 1 person, 6.25%
  9. Hypopharyngeal Cancer: 1 person, 6.25%
  10. High Blood Pressure: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Iressa and Benadryl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Iressa and Benadryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Iressa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benadryl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Iressa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benadryl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gefitinib and diphenhydramine hydrochloride (the active ingredients of Iressa and Benadryl, respectively), and Iressa and Benadryl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: